Top Markets
Coin of the day
NanoVibronix, Inc. NanoVibronix, Inc.

NanoVibronix, Inc.

NAOV
Rang in Aktien #37687
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd.,... NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain. Key among their product line is UroShield, an ultrasound-based solution engineered to deter bacterial colonization and biofilm development in urinary catheters, thereby boosting antibiotic efficacy and reducing associated patient discomfort. They also offer PainShield and WoundShield, both patch-based therapeutic ultrasound technologies. PainShield targets relief from pain, muscle spasms, and joint contractures, while WoundShield is designed to foster tissue regeneration and promote healing in wounds. The company distributes these products directly to consumers and via extensive distributor networks spanning the United States, Israel, Europe, India, and numerous other international regions. Founded in 2003, NanoVibronix, Inc. maintains its corporate headquarters in Elmsford, New York.
Aktienkurs
$1.90
Zuletzt synchronisiert: 2026-03-11
Marktkapitalisierung
$1.51M
Veränderung (1 Tag)
-41.54%
Veränderung (1 Jahr)
-67.58%
Land
US
Handel NanoVibronix, Inc. (NAOV)

Kategorie

Kursverlauf für NanoVibronix, Inc. (NAOV)
Höchster Schlusskurs: $1.90 am 2026-03-01

Niedrigster Schlusskurs: $7.70K am 2015-05-01
Kursverlauf der Aktie von NanoVibronix, Inc. von 2015 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 29.25%
2025 -95.05%
2024 -37.77%
2023 -84.33%
2022 -69.09%
2021 14.68%
2020 -67.50%
2019 -15.76%
2018 -24.85%
2017 -23.62%
2016 21.79%
2015 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$111.15 -15.64%
US
$339.00 -11.24%
US
$91.19 -1.97%
IE
$51.77 -49.83%
US
$91.49 16.90%
US